Clinical Trial

Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Study acronym: PLAQSEPSIS
Recruiting
View on ClinicalTrials.gov →
Summary
: Sepsis, now defined as life-threatening organ dysfunction due to a dysregulated host response to infection, is an important global health problem representing about a fifth of all global deaths. It can be associated, in some cases, with multiple organ failure and cytokine storm. The main objective of this study is to estimate and to compare the activation rate of the Nucleotide-binding domain Leucine Rich repeat containing Protein 3 (NLRP3) inflammasome in platelets between five groups of patients suffering from bacterial and/or viral sepsis, with different severity levels according to Sequential Organ Failure Assessment (SOFA) score to precise the platelets' implication in this cytokine storm.
Trial Details
NCT Number NCT06657781
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Conditions Bacterial Sepsis
Enrollment 171 participants
Start Date 2022-11-30
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2024-10-24